Applicable groups for larotrectinib

Larotrectinib is a targeted anti-cancer drug suitable for the treatment of a specific type of tumor. Its main applicable population is cancer patients suffering from TRK (neuroprimitive ectodermal tumor) gene fusion.

TRK gene fusion refers to the fusion of the NTRK gene in the body with other genes to produce new and abnormal TRK proteins. This gene fusion is relatively common in some cancers, including multiple tumor types in infants, children, and adults, such as childhood soft tissue sarcoma, thyroid cancer, lung cancer, and others.

Larotrectinib blocks this key signaling pathway in cancer development by inhibiting the activity of abnormalTRK protein. For tumors positive for TRK gene fusion, larotrectinib shows significant therapeutic effects and can cause tumor shrinkage or stabilization.

Importantly, larotrectinib is an individualized treatment, that is, treatment is based on the specific situation of the patient's tumor genotype. Patients will need to undergo genetic testing to confirm the presence of theTRKgene fusion to determine whether they are candidates for larotrectinib. Because it is highly targeted, this treatment offers hope in some TRK gene fusion-positive cancer patients and demonstrates the potential of personalized medicine in the field of cancer treatment. Before use, patients should consult their physician about specific genetic testing and treatment options.

Larotrectinib has been launched in China and has not yet been included in medical insurance. Since it has not been launched in China for a long time, it may be difficult to purchase it in hospitals. For specific conditions, it is recommended to consult the local hospital pharmacy. In foreign markets, larotinib has two options: original drug and generic drug. Original drugs include the German version, the American version, the European version and the Hong Kong version, and the price is about 10,000 to 20,000 yuan. In comparison, generic drugs are much cheaper. There are Lao and Bangladeshi versions of generic drugs, and the price is around two to three thousand. It is worth noting that the ingredients of original drugs and generic drugs are basically the same.